...
首页> 外文期刊>FEBS letters. >Kinesin-1 inhibits the aggregation of amyloid-beta peptide as detected by fluorescence cross-correlation spectroscopy
【24h】

Kinesin-1 inhibits the aggregation of amyloid-beta peptide as detected by fluorescence cross-correlation spectroscopy

机译:如荧光互相关光谱所检测,Kinesin-1抑制淀粉样β肽的聚集

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Although the exact etiology and pathogenesis of Alzheimer's disease (AD) are still unclear, amyloid-beta (A beta) generated by the proteolytic processing of amyloid-b precursor protein (APP) aggregate to form toxic amyloid species. Kinesin-1 is the first identified ATP-dependent axonal transport motor protein that has been proven to affect A beta generation and deposition. In this paper, we applied dual-color fluorescence cross-correlation spectroscopy (DC-FCCS) to investigate the direct interaction of A beta with kinesin-1 at the single-molecule fluorescence level in vitro. The results showed that two kinds of enhanced green fluorescent protein (EGFP)-tagged kinesin light-chain subunits of kinesin-1(KLCs), KLC-E and E-KLC inhibited the aggregation of A beta over a period of time, providing additional insight into the mechanism of axonal transport deficits in AD.
机译:尽管尚不清楚阿尔茨海默氏病(AD)的确切病因和发病机理,但通过淀粉样蛋白-b前体蛋白(APP)的蛋白水解加工产生的淀粉样蛋白-β(A beta)聚集形成有毒的淀粉样蛋白。 Kinesin-1是第一个鉴定出的ATP依赖性轴突转运运动蛋白,已被证明可影响A beta的生成和沉积。在本文中,我们应用双色荧光互相关光谱法(DC-FCCS)在体外单分子荧光水平下研究A beta与kinesin-1的直接相互作用。结果表明,KCS-E和E-KLC这两种增强型绿色荧光蛋白(EGFP)标记的驱动蛋白轻链亚基KLC-E和E-KLC在一段时间内抑制了A beta的聚集,提供了更多深入了解AD轴突运输缺陷的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号